1095. Pharmacokinetics-Pharmacodynamics Evaluation of Tebipenem Pivoxil Hydrobromide Using the 10-Day Hollow-Fiber In Vitro Infection Model

BACKGROUND: Tebipenem pivoxil hydrobromide, an orally bioavailable prodrug of tebipenem, is currently in development for the treatment of complicated urinary tract infections. The spectrum of tebipenem activity against Enterobacterales is consistent with intravenous carbapenems such as ertapenem and...

Descripción completa

Detalles Bibliográficos
Autores principales: VanScoy, Brian D, Conde, Haley, Jones, Sean, Critchley, Ian A, Parr, Thomas R, Cotroneo, Nicole, Ambrose, Paul G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644322/
http://dx.doi.org/10.1093/ofid/ofab466.1289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644322/
http://dx.doi.org/10.1093/ofid/ofab466.1289

Ejemplares similares